Translational research on chronic rejection after lung transplantation: towards better treatment in patients. KU Leuven
My BOF−ZAP project is part of the BREATHE research group and includes research into rejection after lung transplantation focusing on structural changes of the lung and the allo-immune response. This research ranges from basic experimental research in cell cultures and laboratory animals to translation to the human lung and the patient. The final objective remains to increase the quality and survival of the lung transplant patient. We aim to ...
DonoR-specific antilbodiES in cryo-bioPsIes and bRonchoAlveolar lavage fluid during rejecTIOn after luNg transplantation [Acronym: RESPIRATION] KU Leuven
Technical optimisation and clinical validation of a novel urinary biomarker for antibody-mediated rejection after kidney transplantation KU Leuven
Home-based PHysical rehabilitatiOn after livEr traNsplantation and Impact of eXercise intensity: a Randomized Controlled Trial [PHOENIX-RCT] KU Leuven
Wise men beyond borders. The transplantation of the French conseil de prud'hommes throughout Europe. Ghent University
This research aims to map the transplantation of the French conseil de prudU+2019hommes across Europe and to compare its evolution in five countries in detail. This should enable us to gain insight into the development of specialised labour courts, but will also contribute to a much-needed clearer understanding of the conditions for a successful transplantation of legal rules or institutions.
Transcriptome-based management of transplant-related pulmonary fibrosis in chronic pulmonary rejection after lung or allogeneic stem cell transplantation KU Leuven
Background Chronic lung allograft dysfunction (CLAD) and chronic pulmonary graft versus host disease (cGvHD) are life-threatening conditions commonly encountered after lung transplantation and allogeneic hematopoietic stem cell transplantation. Pathophysiological and molecular pathways associated with transplant-related pulmonary fibrosis leading to structural changes and lung failure in CLAD pulmonary cGvHD remain unknown. Aims The primary ...